Track Orchestra BioMed Holdings's long-term debt ($730K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), OBIO shows a long-term debt of $730K. That compares with $1.5M in the prior-year period — down 51.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, OBIO's long-term debt is now $730K (was $1.5M) — a 51.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orchestra BioMed Holdings is outperforming or lagging.
Tracking OBIO's long-term debt over time shows whether Orchestra BioMed Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $730K That compares with $1.5M in the prior-year period — down 51.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Orchestra BioMed Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $730K) with ownership activity and broader fundamentals.